CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs

    Important immunotherapy breakthroughs benefited patients immensely in 2017 and paved the way for even more advances in…

    December 28, 2017| Arthur N. Brodsky, PhD
  • CICON17 Day 1 Recap: Neoantigens, Vaccines, and Overcoming Immunotherapy Resistance

    Day 1 of CICON17 explored how to identify and target neoantigens with vaccines and other strategies to…

    September 7, 2017| Arthur N. Brodsky, PhD
  • AACR17 Update: CAR T Cells, Regulatory T Cells, and the Future of Immunotherapy

    Day two addressed several strategies to improve immunotherapy’s precision and effectiveness

    April 2, 2017| Arthur N. Brodsky, PhD
  • New Study: Vaccine Holds Promise in Treating Cervical Pre-Cancer

    The vaccine could provide a new treatment option for patients with high-risk cervical pre-cancer. 

    September 25, 2015| Matthew Tontonoz
  • Found: A Molecular Needle in the Cancer Haystack

    New research by CRI scientists shows how genomic methods can be used to create a personalized cancer…

    November 27, 2014| Matthew Tontonoz
  • Making Pancreatic Cancer a Target for Immunotherapy

    Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.

    June 18, 2014| Matthew Tontonoz
  • Breast Cancer Vaccine Shows Success for Treating Osteosarcoma in Dogs

    A cancer immunotherapy originally designed for treating breast cancer in people may also be effective for treating…

    March 5, 2014| Michelle Liew
  • New Treatment Strategy Coaxes Cancer Out of Hiding

    Recent published findings by CRI scientist Dr. Kunle Odunsi show combination of chemotherapy and a cancer vaccine…

    January 10, 2014| Matthew Tontonoz
  • The Power of Immunotherapy for Gynecologic Cancers

    September is Gynecologic Awareness Month. Of all gynecologic cancers, ovarian is one of the major types for…

    September 25, 2013| Hannah Belisle
Previous Page
1 2

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute